###### Strengths and limitations of this study

-   The main strength of this study is the longitudinal prospective design over 2 years within primary healthcare and high long-term follow-up (95%).

-   Measurements representing all the domains of International Classification of Functioning, Disability and Health complemented with lifestyle behavioural factors.

-   The limitation of this study is the small sample size and that we included only women which limits the generalisability to men.

Introduction {#s1}
============

Non-specific chronic low back pain (CLBP), defined as pain duration \>3 months, is associated with variations of recurrent or persistent pain.[@R1] CLBP has various impact on body functions, activity and participation in daily life[@R1] and it is a common cause for attending healthcare.[@R1]

Non-specific acute low back pain (LBP) is described to have a spontaneous course.[@R1] However, after 1 year 63%--82% of primary care patients with LBP report to have recurrent LBP and 20%--45% impaired function.[@R6] Prognostic factors for the transition from non-specific acute LBP to CLBP have previously been described in personal and socioeconomic areas as well as in all domains of the International Classification of Functioning, Disability and Health (ICF).[@R6] Women seems to have a greater risk for CLBP[@R6] and when studying prognostic factors it is suggested to assess women separately.[@R19] Previous prognostic models for the transition to CLBP explain 28%--51% of variability in the measured outcome.[@R22] The outcomes, combination of included prognostic factors and statistical analyses often differ between studies, making comparisons or meta-analysis difficult.[@R18]

Some studies have described similar prognostic factors for persistent CLBP as for the transition from non-specific acute LBP to CLBP.[@R23] Since the course of non-specific acute LBP and CLBP differs, more knowledge of prognostic factors for varying outcomes in patients with CLBP is warranted.[@R25] A previous review studying prognostic factors for delayed recovery in CLBP found no association between age, sex and the outcome measure of pain intensity and disability at short-term follow-up (eg, 6 weeks). Conflicting evidence was found for fear of avoidance as a predictor.[@R26] At long-term follow-up (eg, 6 months), no association was found between smoking, pain intensity, fear of avoidance and the dependent variable disability.[@R26] Conflicting evidence was found for age, sex and physical job demands and the outcome measure of pain intensity and disability. Moreover, conflicting evidence was found for the association between age, activities of daily living, pain intensity and physical job demand and the outcome return to work.[@R26] However, recently a study showed that a physical performance test (6 min walk test (6MWT)), depression and earlier work ability predicted later work ability in women with CLBP.[@R27]

The knowledge about various prognostic factors for the recovery in the long term for patients with CLBP is still insufficient. This study is an extended analysis of the material from the 2-year longitudinal cohort study of prognostic factors for work ability in women with CLBP.[@R27] The present study aims to focus on the prognostic value of lifestyle behavioural factors, stress symptoms and physical performance for future activity limitation using the same material and measurements.

The aim was to assess if body function, activity, participation, health-related quality of life and lifestyle behavioural factors can predict the future variance of self-rated activity limitation in women with CLBP in primary healthcare (PHC) 2 years later.

Methods {#s2}
=======

Study design {#s2a}
------------

This 2-year prospective longitudinal cohort study included women (n=130) with CLBP within PHC.[@R28] Patients were assessed at baseline and were reassessed after 2 years. Predictors for later self-reported activity limitation (Roland Morris disability questionnaire (RMDQ)) were analysed by multivariate linear regression. Independent variables found to be associated with disability in patients with CLBP[@R27] were complemented with lifestyle behavioural factors including body mass index (BMI), smoking, alcohol consumption, sleep quantity and quality, leisure time physical activity and a questionnaire of the clinical manifestation of stress. Other independent variables related to chronic pain were pain localisation, pain intensity, fatigue, anxiety, depression, work status, private social support health-related quality of life and two measures of physical performance.

Participants were assessed by a trained physical therapist in PHC both at baseline and after 2 years and included a structured interview, measure of body height and weight, and the two physical performance tests. Participants were asked to fill in a package of self-administrated questionnaires at the assessment and two at home. They were provided with a prepaid addressed envelope to return questionnaires. If no questionnaires were returned within 2 weeks, a reminder by telephone was made. Written informed consent was obtained from all patients.

Selection of patients {#s2b}
---------------------

Female patients were identified by systematic search in medical charts for LBP diagnoses 'M545' (International Classification of Diseases, tenth revision) at eight PHC clinics in southwestern Sweden, a mixture of urban and rural populations, in 2004--2005. All patients who could be contacted, accepting participation and fulfilling the inclusion criteria were invited to enrol in the study. The inclusion criteria were female patient, LBP (pain between costal margins and gluteal folds) with or without referred leg pain.[@R1] Further inclusion criteria were \>12-week duration of symptoms, not pregnant, no known spinal pathology, no other severe comorbidity (eg, cancer, fracture, stroke, severe psychiatric disorders, mental retardation), age between 18 and 60 years, understanding and fluent in Swedish. At the 2-year follow-up, all patients included in the cross-sectional study (n=130),[@R28] who could be contacted and accepting participation, were invited to the follow-up, containing the same study protocol as at baseline.

Measurements {#s2c}
------------

The structured interview included questions about age, nationality, education level, family situation, work status, back pain history (onset, duration and symptoms), comorbidity and pharmacological treatment.

### Lifestyle behavioural factors {#s2c1}

#### Body mass index {#s2c1a}

Height and weight were assessed for calculating the BMI (kg/m^2^).

#### Alcohol consumption {#s2c1b}

For alcohol consumption, the Alcohol Use Disorders Identification Test (AUDIT-C)[@R29] was used (range 0--12). Higher scores indicate higher alcohol consumption.

#### Smoking {#s2c1c}

Tobacco use was dichotomised into two categories, no smoker or smoker. The category no smoker required to never been smoking. The category smoker required to previously been a smoker or are reported to be currently smoking.

#### Sleep {#s2c1d}

For sleep quantity and quality, two questions was used.[@R30] 'Do you think you get enough sleep?' (range 1--4) and 'On the whole, how do you think you sleep?" (range 1--4). Higher score indicates better sleep quantity and quality.

#### Stress symptoms {#s2c1e}

To quantify clinical manifestations of stress symptoms, the Stress and Crises Inventory (SCI-93) was used (range 0--140) where higher scores indicate more severe clinical stress symptoms.[@R31] A total score of ≤38 indicates normal resources for activity and work.[@R33]

#### Physical activity at leisure time {#s2c1f}

The leisure time physical activity instrument (LTPAI) was used to assess the amount of physical activity in leisure time during a typical week.[@R34] The number of hours spent for light, moderate and vigorous activities was registered and the total number of hours was used.[@R34]

### Body function {#s2c2}

#### Physical performance tests {#s2c2a}

The 6MWT was used to assess physical performance.[@R35] The distance (metre) is measured while the patient walks up and down a 30 m corridor for 6 min. The participant was instructed to walk as quickly as possible without running.

Hand grip strength was measured with an electronic instrument Grippit.[@R38] A sustained voluntary 10 s contraction was measured. The right-hand value was used for analyses in the present study.

#### Number of pain localisation, pain intensity and fatigue {#s2c2b}

For pain distribution, a drawing of the body was used to register pain localisations (0--18).[@R40] Pain intensity and fatigue during the last week was measured on a visual analogue scale (VAS) 0--100 mm.

#### Distress {#s2c2c}

The Hospital Anxiety and Depression Scale (HADS), HADS-A, was used for assessment of anxiety (range 0--21) and the HADS-D for depression (range 0--21). Higher scores indicate greater anxiety or depression.[@R41]

### Activity limitations {#s2c3}

The RMDQ was used for self-reported activity limitation related to LBP. The RMDQ consists of 24 yes/no statements, where higher scores indicate greater activity limitation (range 0--24).[@R43]

### Participation {#s2c4}

Work status was dichotomised into two categories, work ability or not. The category work ability required work or study, full time or part time, applying for work, parental leave full-time or part-time or part-time disability pension. The category no work ability required full-time sick leave or full-time disability pension. Self-reported sick absenteeism has been shown reliable.[@R44]

### Environmental factors {#s2c5}

The four-item version of Medical Outcome Study Social Support Survey (MOS-SSS) registered private social support: emotional-informational, tangible, affectionate support and positive social interaction (range 1--5 for each item). Higher scores indicate more support (total range 4--20).[@R45]

### Health-related quality of life {#s2c6}

The short-form health survey (SF-36) was used for general health status. The physical component summary (PCS) score and the mental component summary (MCS) score representing an overall health index of physical or mental health (range 0--100) were used.[@R46]

Statistical analysis {#s2d}
--------------------

Group characteristics are presented as mean and SD, median and 25th and 75th percentile or the number and percentage at baseline. Percentage change for RMDQ was constructed by subtracting baseline value from 2-year follow-up value. The change was divided with baseline and multiplied by 100 to create a percentage change.

To enable more meaningful clinical interpretation, small units were transformed to larger ones. In 6MWT, 1 m was transformed to 100 m, in hand grip strength 1 N was transformed to 50 N, in the pain and fatigue scores, 1 mm was transformed to 10 mm (VAS).

Spearman\'s rank correlation between RMDQ at 2 years and each of the independent variables at baseline was performed to evaluate independent variables and reduce the number of independent variables of interest. This analysis was also performed between RMDQ percentages change and each of the independent variables at baseline. Independent variables with p\<0.20 were included in next multivariate regression step.

Two forward stepwise multivariate linear regression analyses were performed, one with RMDQ at 2 years as dependent variable and one with RMDQ percentage change as dependent variable. The independent variables remaining from the first step described above were included.

Prior to the multivariate linear regression, the variables were evaluated for the assumptions of multivariate analysis. The dependent variable RMDQ at 2 years fulfilled the assumption of normal distribution when ranked using Blom's formula.[@R49] The statistical criteria for the independent variables were 0.05 for entry and 0.10 for removal. Multicollinearity was checked by the values of tolerance and variance inflator factor (VIF). The final models were adjusted for age as it could be a potential confounding factor using standard (Enter) multivariate linear regression. The level of significance for independent variables remaining in the final model was set to 0.05. The IBM SPSS Windows V.22.0 was used for the statistical analyses.

Results {#s3}
=======

Ninety-five per cent (n=123/130) of the participants included in the cross-sectional study[@R28] could be followed up after 2 years ([figure 1](#F1){ref-type="fig"}). Seven patients could not be assessed at the 2-year follow-up, three of them due to pregnancy, an exclusion criteria in the present study. The participants were middle-aged (mean 45 (SD 10) years), mostly educated \>9 years (88%; 108/123), mainly living with another adult (76%; 93/122) and born in Sweden (90%; 111/123) ([table 1](#T1){ref-type="table"}). Seventy-nine per cent (97/123) were categorised as having work ability at baseline. The BMI mean and median values of 27 (SD 5.5) and 26 (25th; 75th percentile 23; 29) indicate that a significant proportion were overweight (≥25 BMI).[@R50] Seventy-six per cent (n=93/123) were currently non-smokers and did not exceed risk consumption of alcohol ([table 2](#T2){ref-type="table"}). Only 14% (17/123) reported sleeping certainly enough and 19% (23/121) reported very good sleep quality ([table 2](#T2){ref-type="table"}). Body function, activity, participation and quality of life at baseline indicates that these aspects of life varied and several of them were not optimal ([table 2](#T2){ref-type="table"}).

###### 

Group characteristics at baseline (n=123)

  ------------------------------------------------ ---------------
  **Personal data**                                
  Age, years (mean (SD))                           45 (10)
  Nationality Swedish (% (n/n))                    90% (111/123)
  Symptom duration, years (mean (SD))              9.6 (8.8)
  **Education status (% (n/n))**                   
   ≤9 years                                        12% (15/123)
   10--12 years                                    40% (49/123)
   \>12 years                                      48% (59/123)
  **Social status (% (n/n))**                      
   Living with an adult                            26% (32/122)
   Living with an adult and child/children         50% (61/122)
   Living alone                                    12% (14/122)
   Living alone with child/children                9.0% (11/122)
   Living apart with an adult                      3.3% (4/122)
  **Pharmacological treatment, yes (% (n/n))\***   
   Analgesics                                      53% (65/123)
   Psychotropic drugs                              16% (20/123)
  **Employment status (% (n/n))**                  
   Currently working and/or studying               58% (71/123)
   Sick leave, full time                           11% (13/123)
   Sick leave, part time                           8.9% (11/123)
   Disability pension, full time                   11% (13/123)
   Disability pension, part time                   5.7% (7/123)
   Parental leave, full time                       1.6% (2/123)
   Parental leave, part time                       1.6% (2/123)
   Unemployed, full time                           0.81% (1/123)
   Unemployed, part time                           2.4% (3/123)
  ------------------------------------------------ ---------------

\*The use last month registered by yes or no.

###### 

Lifestyle factors, body function, activity, participation and health-related quality of life at baseline (n=123)

  **Lifestyle behavioural factors**            
  -------------------------------------------- ----------------------------
  Body mass index (kg/m^2^)\*                  27 (5.5)---26 (23; 29)
  AUDIT-C (0--12)†                             2.2 (1.4)---2.0 (1.0; 3.0)
  Smoking \[% (n/n)\]                          
   Never smoked                                40% (49/123)
   Previously smoked                           36% (44/123)
   Currently smoking                           20% (25/123)
   Currently snuffing                          4% (5/123)
  Sleep quantity (% (n/n))‡                    
   Certainly enough                            14% (17/123)
   Broadly enough                              47% (58/123)
   Some shortage                               24% (29/123)
   Clearly insufficient                        15% (19/123)
  Sleep quality (% (n/n))§                     
   Very good                                   19% (23/121)
   Quite good                                  51% (62/121)
   Quite bad                                   21% 25/121)
   Very bad                                    9% (11/121)
  SCI-93¶                                      36 (21)---35 (19; 51)
  LTPAI, hours per week (n=122)\*\*            7.8 (8.5)---6.0 (3.4; 9.0)
  **Body function**                            
   Pain localisations (0--18)††                4.6 (3.2)---4.0 (2.0; 6.0)
   Pain intensity (VAS 0--100 mm)‡‡            45 (27)---45 (24; 68)
   Fatigue (VAS 0--100 mm)‡‡                   53 (29)---53 (28; 75)
   6MWT (m) (n=121)                            572 (86)---581 (515; 633)
   Hand grip strength (N)                      232 (76)---237 (184; 285)
   HADS-A (0--21)§§                            6.4 (4.4)---5.0 (3.0; 9.0)
   HADS-D (0--21)§§                            4.3 (3.6)---3.0 (1.0; 7.0)
  **Activity (n=121)**                         
   RMDQ (0-24)¶¶                               8.4 (4.8)---7.0 (4.0; 12)
  **Participation**                            
   Work ability (yes) (% (n/n))                79% (97/123)
  **Environmental factors**                    
   Private social support (4--20)\*\*\*        16 (3.5)---17 (14; 19)
  **Health-related quality of life (n=122)**   
   PCS (0--100)†††                             38 (9.9)---39 (31; 47)
   MCS (0--100)†††                             46 (13)---49 (37; 56)

\*First figure mean values (SD). Second figure median values (25th; 75th percentile).

†The AUDIT-C, three items. Higher scores reflect higher alcohol consumption (0--12).

‡One item: 'Do you think you get enough sleep?'

§One item: 'On the whole, how do you think you sleep?'

¶Higher scores indicate more severe clinical stress symptoms (0--140).

\*\*LTPAI assesses the total hours of physical activity in leisure time during a typical week.

††Self-reported pain locations registered by a figure with predefined body locations (0--18).

‡‡Perceived pain intensity, fatigue over the last week rated on a VAS (0--100). Higher values indicate more pain, fatigue.

§§Higher scores indicate more anxiety (0--21) and depression (0--21).

¶¶RMDQ indicates disability related to low back pain (0--24) at baseline. Higher scores indicate more severe disability.

\*\*\*Medical Outcome Study Social Support Survey (four-item scale) reflects private social support ranging from 1 to 5. Higher scores reflect more perceived support (4-20).

†††SF-36. The PCS score (0--100) and MCS score (0--100).

6MWT, 6 min walk test; AUDIT-C, Alcohol Use Disorders Identification Test; HADS-A and HADS-D, Hospital Anxiety and Depression Scale; LTPAI, leisure time physical activity instrument; MCS, mental component summary; PCS, physical component summary; RMDQ, Roland Morris disability questionnaire; SCI-93, Stress and Crisis Inventory; SF-36, short-form health survey; VAS, visual analogue scale.

![Participants flow. ICD-10, International Classification of Diseases, tenth revision; LBP, low back pain.](bmjopen-2016-013974f01){#F1}

Two-year follow-up RMDQ status {#s3a}
------------------------------

There was a statistically significant mean decrease of 1.9 points (95% CI 1.2 to 2.5) on RMDQ from 8.4 (SD 4.8) at baseline to 6.4 (SD 5.5) at the 2-year follow-up (−23%, p\<0.0001).

Predictors for activity limitation (RMDQ) at the 2-year follow-up {#s3b}
-----------------------------------------------------------------

The stepwise multivariate regression analysis showed that the 6MWT, SCI-93 and RMDQ at baseline were the most important predictors explaining 54% of variance in the RMDQ at the 2-year follow-up ([table 3](#T3){ref-type="table"}). A model including age, 6MWT and SCI-93 made statistically significant contribution with adjusted R^2^of 0.39. However, a model including only RMDQ (with or without addition of age) gave an R^2^ of 0.51. Models with 6MTW or SCI-93 alone gave R^2^ of 0.20 and 0.25, respectively.

###### 

Prognostic factors at baseline for activity limitation at the later 2-year follow-up using the Roland Morris disability questionnaire (RMDQ) at 2-year follow-up (n=120)

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                  Spearman's rank correlation\       Forward stepwise multivariate linear regression\*\                                                             
                                                  Correlation with RMDQ at 2 years   Independent variables p\<0.20 entered in the model, adjusted for age\                                          
                                                                                     R^2^=0.54 for the overall model                                                                                
  ----------------------------------------------- ---------------------------------- ----------------------------------------------------------------------- ---------- --------------------------- ----------
  Age, years                                      120                                0.067                                                                   0.47       −0.0048 (−0.019 to 0.010)   0.51

  Lifestyle behavioural factors                                                                                                                                                                     

   Body mass index (kg/m^2^)                      119                                0.21                                                                    0.021                                  

   Smoker (n=72)---non-smoker (n=48)              120                                0.14                                                                    0.14                                   

   AUDIT-C (0--12)†                               118                                −0.23                                                                   0.011                                  

   Sleep quantity (1--4)‡                         120                                −0.34                                                                   0.00014                                

   Sleep quality (1--4)§                          118                                −0.43                                                                   \<0.0001                               

   SCI-93¶                                        120                                0.48                                                                    \<0.0001   0.0091 (0.0023 to 0.016)    0.0088

   LTPAI (hours per week)\*\*                     119                                −0.11                                                                   0.24                                   

  Body function                                                                                                                                                                                     

   Pain localisations (0--18)††                   120                                0.36                                                                    0.000052                               

   Pain intensity 10 mm (VAS 0--100)‡‡            120                                0.20                                                                    0.027                                  

   Fatigue 10 mm (VAS 0--100)‡‡                   120                                0.24                                                                    0.0078                                 

   6MWT, 100 m                                    118                                −0.41                                                                   \<0.0001   −0.23 (−0.42 to −0.036)     0.020

   Hand grip strength 50 (N)                      120                                −0.17                                                                   0.070                                  

   HADS-A (0--21) §§                              120                                0.16                                                                    0.089                                  

   HADS-D (0--21)§§                               120                                0.37                                                                    0.000025                               

  Activity                                                                                                                                                                                          

   RMDQ at baseline (0--24)¶¶                     118                                0.71                                                                    \<0.0001   0.10 (0.068 to 0.14)        \<0.0001

  Participation                                                                                                                                                                                     

   Work ability (n=95)---no work ability (n=25)   120                                −0.37                                                                   0.000026                               

  Environmental factors                                                                                                                                                                             

   Private social support (4--20)\*\*\*           120                                −0.29                                                                   0.0013                                 

  Health-related quality of life                                                                                                                                                                    

   PCS (0--100)†††                                119                                −0.42                                                                   \<0.0001                               

   MCS (0--100)†††                                119                                −0.28                                                                   0.0022                                 
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*RMDQ score was transformed to ranked normal score of RMDQ using Blom's formula. The final model was adjusted for age using standard (Enter) multivariate linear regression.

†The AUDIT-C, three items. Higher scores reflect higher alcohol consumption (0--12).

‡One item: 'Do you think you get enough sleep?'. Higher scores indicate better sleep (1--4).

§One item: 'On the whole, how do you think you sleep?'. Higher scores indicate better sleep (1--4).

¶Higher scores indicate more severe clinical stress symptoms (0--140).

\*\*The LTPAI assesses the total hours of physical activity in leisure time during a typical week.

††Self-reported pain locations registered by a figure with predefined body locations (0--18).

‡‡Perceived pain intensity, fatigue over the last week rated on a VAS (0--100). Higher values indicate more pain, fatigue.

§§Higher scores indicate more anxiety (0--21) and depression (0--21).

¶¶RMDQ indicates disability related to low back pain (0--24) at baseline. Higher scores indicate more severe disability.

\*\*\*Medical Outcome Study Social Support Survey (four-item scale) reflects private social support ranging from 1 to 5. Higher scores reflect more perceived support (4--20).

†††SF-36. The PCS score (0--100) and MCS score (0--100).

6MWT, 6 min walk test; AUDIT-C, Alcohol Use Disorders Identification Test; HADS-A and HADS-D, Hospital Anxiety and Depression Scale; LTPAI, leisure time physical activity instrument; MCS, mental component summary; PCS, physical component summary; SCI-93, Stress and Crisis Inventory; SF-36, short-form health survey; VAS, visual analogue scale.

There were no significant associations between percentage change in RMDQ and any of the independent variables ([table 4](#T4){ref-type="table"}).

###### 

Prognostic factors at baseline for percentage change in the Roland Morris disability questionnaire (RMDQ) (n=115)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                  Spearman's rank correlation\                 Forward stepwise multivariate linear regression\*\                                                          
                                                  Correlation with percentage change in RMDQ   Independent variables p\<0.20 entered in the model, adjusted for age\                                       
                                                                                               No significant association                                                                                  
  ----------------------------------------------- -------------------------------------------- ----------------------------------------------------------------------- ------- --------------------------- ------
  Age, years                                      115                                          −0.11                                                                   0.23    −0.0017 (−0.014 to 0.011)   0.79

  Lifestyle behavioural factors                                                                                                                                                                            

   Body mass index (kg/m^2^)                      114                                          −0.13                                                                   0.18                                

   Smoker (n=72)---non-smoker (n=48)              115                                          −0.072                                                                  0.44                                

   AUDIT-C (0--12)†                               113                                          0.11                                                                    0.23                                

   Sleep quantity (1--4)‡                         115                                          0.18                                                                    0.054                               

   Sleep quality (1--4)§                          113                                          0.16                                                                    0.099                               

   SCI-93¶                                        115                                          −0.17                                                                   0.075                               

   LTPAI (hours per week)\*\*                     115                                          0.13                                                                    0.18                                

  Body function                                                                                                                                                                                            

   Pain localisations (0--18)††                   115                                          −0.15                                                                   0.10                                

   Pain intensity 10 mm (VAS 0-100)‡‡             115                                          0.078                                                                   0.41                                

   Fatigue 10 mm (VAS 0-100)‡‡                    115                                          −0.046                                                                  0.62                                

   6MWT, 100 m                                    113                                          0.17                                                                    0.065                               

   Hand grip strength 50 (N)                      115                                          0.057                                                                   0.55                                

   HADS-A (0--21) §§                              115                                          −0.023                                                                  0.81                                

   HADS-D (0--21)§§                               115                                          −0.11                                                                   0.24                                

  Participation                                                                                                                                                                                            

   Work ability (n=95)---no work ability (n=25)   115                                          0.15                                                                    0.11                                

  Environmental factors                                                                                                                                                                                    

   Private social support (4--20)¶¶               115                                          0.14                                                                    0.14                                

  Health-related quality of life                                                                                                                                                                           

   PCS (0--100)\*\*\*                             114                                          0.029                                                                   0.76                                

   MCS (0--100)\*\*\*                             114                                          0.14                                                                    0.13                                
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Percentage change in RMDQ as dependent variable. The final model was adjusted for age using standard (Enter) multivariate linear regression.

†The AUDIT-C, three items. Higher scores reflect higher alcohol consumption (0--12).

‡One item: 'Do you think you get enough sleep?'. Higher scores indicate better sleep (1--4).

§One item: 'On the whole, how do you think you sleep?'. Higher scores indicate better sleep (1--4).

¶Higher scores indicate more severe clinical stress symptoms (0--140).

\*\*The LTPAI assesses the total hours of physical activity in leisure time during a typical week.

††Self-reported pain locations registered by a figure with predefined body locations (0--18).

‡‡Perceived pain intensity, fatigue over the last week rated on a VAS (0--100). Higher values indicate more pain, fatigue.

§§Higher scores indicate more anxiety (0--21) and depression (0--21).

¶¶Medical Outcome Study Social Support Survey (four-item scale) reflects private social support ranging from 1 to 5. Higher scores reflect more perceived support (4--20).

\*\*\*SF-36. The PCS score (0--100) and MCS score (0--100).

6MWT, 6 min walk test; AUDIT-C, Alcohol Use Disorders Identification Test; HADS-A and HADS-D, Hospital Anxiety and Depression Scale; LTPAI, leisure time physical activity instrument; MCS, mental component summary; PCS, physical component summary; SCI-93, Stress and Crisis Inventory; SF-36, short-form health survey; VAS, visual analogue scale.

Discussion {#s4}
==========

This 2-year prospective cohort study of women with CLBP attending PHC showed that lower performance in walking capacity (6MWT), more severe clinical stress symptoms (SCI-93) and more severe activity limitation (RMDQ) at baseline predicted more activity limitation (RMDQ) after 2 years ([table 3](#T3){ref-type="table"}). The model with these three predictors explained 54% of the variance in self-reported activity limitation (RMDQ) at the 2-year follow-up, which is similar to a previous review of prediction models including various predictors for disability in patients with subacute non-specific LBP.[@R22]

Strengths and limitations {#s4a}
-------------------------

This study included measurements representing all the domains of ICF[@R17] complemented with lifestyle behavioural factors, which is considered as a main strength. The follow-up frequency was very high with 95% being followed up.

Prevalence and predictors of chronic pain have been studied in general populations,[@R21] while the present study assessed women with CLBP consulting PHC, contributing with knowledge for healthcare professionals working in PHC. Previous studies found that chronic pain is more common in women, and that women are at greater risk of chronic pain and disability.[@R6] It has been suggested that women should be assessed separately when studying prognostic factors for LBP,[@R19] hence the present study included only female patients.

The initial decision to collect variables was based on previous studies indicating suitable variables of potential interest. However, this decision led to a large number of variables and a further sorting mechanism was needed before the final multivariate regression model. This sorting mechanism could be done either by further using clinical reasoning and prior knowledge or by looking at statistical significance. Each of these approaches will have a different risk for bias. Using clinical reasoning and prior knowledge may make us blind to new knowledge that previous studies missed. Using the approach we finally chose, bivariate correlation in Spearman's rank correlation may cause clinically insignificant findings to be put forward.

Hence, each independent variable was first evaluated in this bivariate analysis. Second, the multivariate model was built by using the independent variables with p\<0.20 in the rank correlation. Physical performance (6MWT) was included in the final model. Knowing that age influences physical performance, age was included as a potential confounder, even though it was not correlated with RMDQ.

The main reason for deploying a sorting mechanism (Spearman's rank correlation) before doing the multivariate regression was to reduce the problem which may occur when there are few participants relative to the number of independent variables. Hence, the number of participants was considered to be sufficient for the final model.

Prior to the multiple regression, the independent variables were also evaluated for assumptions of multivariate analysis including checking for multicollinearity and singularity. The values of tolerance (0.52--0.74) and VIF (1.3--1.9) were checked indicating low correlation between the independent variables. Moreover, questionnaires total scores were used to avoid singularity.

Self-administrated questionnaires are recommended for the assessment of activity limitation in patients with LBP.[@R52] The present study used RMDQ as the outcome measure at the 2-year follow-up. The RMDQ is considered valid, commonly used and recommended in LBP research for monitoring disability.[@R53] Seventeen statements in the RMDQ are reported to be linked to the activity component in the ICF.[@R55] However, self-reports may suffer from the fact that some patients may underestimate or overestimate their limitations and physical performance tests are suggested to complement self-reports.[@R57] Walk capacity (6MWT) and hand grip strength, semiobjective measures of body function, were therefore included as potential predictors in this study.

The group showed a moderate grade of disability, RMDQ 8.4 (SD 4.8), at baseline which might reflect that the women included were not in acute need for treatment when recruited. There was a statistically significant mean decrease of approximately two points on RMDQ during the 2-year period. Minimal clinical detectable change in the RMDQ is considered to be 2--3 points. Others have suggested a change of 4--5 points to be of clinical value.[@R53]

Predictors for activity limitation (RMDQ) at 2-year follow-up {#s4b}
-------------------------------------------------------------

The BMI values corresponded with overweight (mean 27 (SD 5.5)), which is common in patients with chronic pain[@R28] and might be due to impaired body function, activity limitation and restrictions of participation. A previous 1-year follow-up study found self-reported weight and height (BMI) as a significant predictor for activity limitation.[@R59] However, this could not be confirmed in the present study.

Previously or currently smoking was not found as a predictor, which is concordant to a review studying prognostic factors for pain and disability in CLBP.[@R26] In the present study, hours per week of LTPAI (mean 7.8 (SD 8.5)) was within recommended levels of physical activity[@R60] which might have been the reason for no prognostic value. A healthy lifestyle behaviour, combinations of lifestyles factors, is reported to influence the prognosis of LBP.[@R21] It could be interesting to combine and categorise various self-reported lifestyle behavioural factors for analysing their prognostic value for patients with CLBP. However, in the present study the prognostic values of lifestyle behavioural factors were analysed separately for later self-reported activity limitation in CLBP.

Previous prospective studies of LBP have evaluated body function by measuring spinal motion and muscle strength, showing them to be of poor prognostic value.[@R11] In the present study, the body function assessed by the 6MWT was of prognostic value, showing that lower performance in the 6MWT at baseline predicted more severe activity limitation at 2-year follow-up. Therefore, the 6MWT could be included as a complement to standard clinical examination of CLBP. Physical activity is a recommended intervention for patients with CLBP. The 6MWT is easy to perform and provides information of an individual's physical performance. In the future, the 6MWT might be used as a self-administrated assessment tool to promote physical activity and self-management strategies for patients with CLBP. However, the utility of 6MWT as a self-assessment tool needs to be studied further.

More severe clinical stress symptoms (SCI-93) could independently predict more severe activity limitation (RMDQ) at the 2-year follow-up ([table 3](#T3){ref-type="table"}). The mean score for SCI-93 at baseline was 36 (SD 21) ([table 2](#T2){ref-type="table"}), which indicates an increased level of clinical stress symptoms in the group, compared with the reference values.[@R32] Signs and symptoms in patients with chronic pain are suggested to be associated with prolonged stress,[@R62] but measurement of clinical stress symptoms is not standard in the clinical assessment of patients with CLBP. Therefore, the SCI-93 could provide valuable information for predicting later activity limitation for these patients. Moreover, questionnaires assessing symptoms severity might stimulate the patient's motivation in using active coping strategies to alleviate their stress responses.[@R32] Stress reduction interventions have shown to improve pain acceptance.[@R63] However, if pain acceptance might mediate the association of stress, physical activity and disability need further investigation.

Studies of prognostic factors for patients with acute LBP report similar predictors as this study to the ones in this study.[@R64] However, the characteristics of the patients in the study used to derive the predictive model have to be similar to those in whom the model will be used to. Various factors can impact disability in patients with CLBP (\>12 weeks duration) and function and functional demands often differ between women and men. Therefore, women with CLBP were included in this study.

The baseline activity limitation (RMDQ) was the strongest predictor (R[@R2] 0.51) for activity limitation (RMDQ) at 2 years. The prognostic model including the baseline RMDQ, 6MWT and SCI-93 explained 54% of the variance in activity limitation (RMDQ) at the 2-year follow-up ([table 3](#T3){ref-type="table"}), which is slightly more compared with findings in a previous review of different prognostic models explaining 28%--51% of variance in persisting disability in subacute LBP.[@R22] The 6MWT and SCI-93 may add useful information where the outcome of RMDQ is unavailable.

Knowledge about factors that are associated with the probable recovery or not in CLBP can be used to improve the management of patients with CLBP in primary care. The results of this study can give guidance for interventional trials aiming to improve physical capacity and decrease stress in women with CLBP. The impact of the interaction between prognostic factors and interventions on activity limitation in women with CLBP needs further investigation.

Conclusion {#s5}
==========

A walk test (6MWT), clinical stress symptoms (SCI-93) and activity limitation (RMDQ) predicted future activity limitation in women with CLBP within PHC. The prognostic model including these three predictors explained 54% of the variance in self-reported activity limitation (RMDQ) after 2 years.
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